Search results for "Troponin"

showing 10 items of 187 documents

Reduced reflex sensitivity persists several days after long-lasting stretch-shortening cycle exercise

1999

The mechanisms related to the acute and delayed secondary impairment of the stretch reflex function were investigated after long-lasting stretch-shortening cycle exercise. The results demonstrated a clear deterioration in muscle function immediately after fatigue, which was accompanied by a clear reduction in active and passive reflex sensitivity. For active and passive stretch reflexes, this reduction was biphasic ( P < 0.05 to P < 0.001). However, for the ratio of the electrically induced maximal Hoffmann reflex to the maximal mass compound action potential, only one significant reduction was seen immediately after fatigue (71.2%, P < 0.01). A similar significant ( P < 0.01) d…

AdultMaleReflex StretchLong lastingmedicine.medical_specialtyTime FactorsPhysiologyPhysical ExertionPhysical exerciseElectromyographyRunningH-ReflexPhysiology (medical)Internal medicinemedicineHumansStretch reflexMuscle SkeletalCreatine KinaseMotor Neuronsmedicine.diagnostic_testElectromyographybusiness.industryTroponin ISurgeryElectrophysiologymedicine.anatomical_structureExercise TestLactatesReflexCardiologyRegression AnalysisFemaleStretch-Shortening Cycle ExerciseH-reflexbusinessJournal of Applied Physiology
researchProduct

Diagnostic and prognostic performance of myeloperoxidase plasma levels compared with sensitive troponins in patients admitted with acute onset chest …

2012

Background— Activation of leukocytes with release of myeloperoxidase (MPO) has been linked to acute coronary disease. To date, studies investigating the diagnostic and prognostic performance of circulating MPO in patients with chest pain (CP) are mainly retrospective, of low size, and lack a cut-off value for MPO. Herein, we prospectively assess the diagnostic and prognostic properties of MPO compared with sensitive troponin I (sTNI) in patients admitted to the emergency room with CP. Methods and Results— One thousand, eight hundred and eighteen consecutive patients (mean age, 61.4±13.5 years; 33.6% female) admitted for CP underwent determination of MPO, sTnI, and B-natriuretic peptide pla…

AdultMalemedicine.medical_specialtyAcute coronary syndromeChest PainPopulationMyocardial InfarctionChest painGastroenterologyInternal medicineTroponin INatriuretic Peptide BrainGeneticsmedicineHumansMyocardial infarctioneducationGenetics (clinical)AgedPeroxidaseRetrospective Studieseducation.field_of_studybiologybusiness.industryTroponin IMiddle Agedmedicine.diseasePrognosisTroponinSurgeryROC CurveMyeloperoxidaseAcute Diseasebiology.proteinFemaleMyocardial infarction diagnosismedicine.symptomCardiology and Cardiovascular MedicinebusinessBiomarkersCirculation. Cardiovascular genetics
researchProduct

Glycogen phosphorylase BB in acute coronary syndromes

2005

AbstractThe diagnosis of myocardial damage is preferably based on measurement of the cardiac-specific troponins. However, there is an emerging need for early, specific cardiac markers. One potential candidate is the glycogen phosphorylase BB isoenzyme (GPBB). We investigated the use of a new, commercially available GPBB ELISA assay in 61 patients presenting with an acute coronary syndrome (37 acute myocardial infarction, 24 unstable angina pectoris) in comparison to established cardiac markers such as troponin T, creatine kinase isoenzyme MB (CKMB) mass, and myoglobin. Blood samples were obtained on arrival, as well as 1, 2, 3, 4, 8, 12 and 24h later. GPBB plasma concentrations were elevate…

AdultMalemedicine.medical_specialtyAcute coronary syndromeTime FactorsClinical BiochemistryMyocardial InfarctionCoronary DiseaseEnzyme-Linked Immunosorbent AssayGlycogen phosphorylase isoenzyme BBChest painSensitivity and SpecificityAngina PectorisAnginaTroponin TInternal medicinemedicineCreatine Kinase MB FormHumansPhosphorylase bMyocardial infarctionTroponin TbiologyMyoglobinUnstable anginabusiness.industryBiochemistry (medical)General MedicineMiddle Agedmedicine.diseaseTroponinIsoenzymesAcute DiseaseCardiologybiology.proteinmedicine.symptombusinessBiomarkersClinical Chemistry and Laboratory Medicine (CCLM)
researchProduct

Copeptin Improves Early Diagnosis of Acute Myocardial Infarction

2010

ObjectivesEarly identification of myocardial infarction in chest pain patients is crucial to identify patients at risk and to maintain a fast treatment initiation.BackgroundThe aim of the current investigation is to test whether determination of copeptin, an indirect marker for arginin-vasopressin, adds diagnostic information to cardiac troponin in early evaluation of patients with suspected myocardial infarction.MethodsBetween January 2007 and July 2008, patients with suspected acute coronary syndrome were consecutively enrolled in this multicenter study. Copeptin, troponin T (TnT), myoglobin, and creatine kinase-myocardial band were determined at admission and after 3 and 6 h.ResultsOf 1,…

AdultMalemedicine.medical_specialtyAcute coronary syndromechest paindiagnosisMyocardial InfarctionChest painAngina PectorisCopeptinTroponin TPredictive Value of TestsInternal medicinemedicineHumansMyocardial infarctionProspective StudiesAgedTroponin TtroponinUnstable anginabusiness.industryMyoglobinTroponin IGlycopeptidescopeptinMiddle Agedmedicine.diseaseEarly DiagnosisCardiologyMyocardial infarction complicationsFemaleMyocardial infarction diagnosismedicine.symptombusinessCardiology and Cardiovascular MedicineBiomarkersJournal of the American College of Cardiology
researchProduct

Right bundle branch block and SIQIII-type patterns for risk stratification in acute pulmonary embolism.

2016

Abstract Introduction Risk stratification in acute pulmonary embolism (PE) is crucial for identification of patients with poor prognosis. We aimed to investigate the ECG alterations of right bundle branch block (RBBB) and S I Q III -type patterns for risk stratification in acute PE. Materials and methods Retrospective analysis of PE patients, treated in the Internal Medicine Department, was performed. Patients with RBBB and/or S I Q III -type were compared with those without both patterns. Logistic regression models for association between these ECG alterations and respectively right ventricular dysfunction (RVD), high-risk PE status and myocardial injury were computed. Results 175 patients…

AdultMalemedicine.medical_specialtyBundle-Branch BlockComorbidityRisk AssessmentSensitivity and SpecificityElectrocardiographyInternal medicineGermanyHeart rateTroponin IMedicineHumansDiagnosis Computer-AssistedAgedBundle branch blockmedicine.diagnostic_testbiologybusiness.industryVentilation/perfusion scanIncidenceReproducibility of ResultsRight bundle branch blockMiddle Agedmedicine.diseaseTroponinPulmonary embolismCausalityAcute Diseasebiology.proteinCardiologyFemaleCardiology and Cardiovascular MedicinebusinessPulmonary EmbolismElectrocardiographyJournal of electrocardiology
researchProduct

Identification of acute myocardial infarction in elderly patients using optimized highly sensitive troponin I thresholds

2019

Purpose: Established diagnostic thresholds for high-sensitivity cardiac troponins (hs-cTn) might not apply for elderly patients as they are elevated irrespective of the presence of an acute myocardial infarction (AMI). Aim of the present study was to investigate hs-cTnI in elderly patients with suspected AMI and to calculate optimized diagnostic cutoffs. Material and methods: Data from a prospective multi-centre study and from a second independent prospective single-centre cohort study were analysed. A number of 2903 patients were eligible for further analysis. Patients > 70 years were classified as elderly. hs-cTnI was measured upon admission. Results: Around 34.7% of 2903 patients were…

AdultMalemedicine.medical_specialtyCardiac troponinHealth Toxicology and Mutagenesishealth care facilities manpower and servicesClinical BiochemistryMyocardial InfarctionHyperlipidemias030204 cardiovascular system & hematologyBiochemistrySensitivity and Specificity03 medical and health sciences0302 clinical medicineRisk FactorsInternal medicineTroponin ImedicineHumansMyocardial infarctionProspective Studiescardiovascular diseaseshealth care economics and organizationsAgedAged 80 and overbiologybusiness.industrySmokingTroponin IMiddle Agedmedicine.diseaseTroponinhumanitiesHighly sensitive030220 oncology & carcinogenesisHypertensionCardiologybiology.proteinFemalebusinessBiomarkers
researchProduct

Prognostic usefulness of white blood cell count on admission and one-year outcome in patients with non-ST-segment elevation acute chest pain.

2006

Little is known about the prognostic value of leukocyte count on admission for patients with chest pain. In total, 1,461 patients who presented to the emergency department with non–ST-segment elevation chest pain were studied by clinical history, electrocardiography, serial troponin I determination, and leukocyte count on admission. End points were 1-year mortality and major events (mortality or infarction). Overall patient distribution by quartiles of leukocyte count showed increased mortality (6%, 7%, 6%, and 17%, p = 0.0001) and major events (13%, 13%, 15%, and 24%, p = 0.0001) in the fourth quartile. After adjustment for other risk factors, the fourth quartile cut-off value (>10,000 cel…

AdultMalemedicine.medical_specialtyChest PainMyocardial InfarctionChest painElectrocardiographyLeukocyte CountPatient AdmissionWhite blood cellInternal medicineTroponin IOutcome Assessment Health CareDiabetes MellitusMedicineST segmentHumansMyocardial infarctionAgedST depressionAged 80 and overbusiness.industryST elevationHazard ratioTroponin IAge FactorsMiddle Agedmedicine.diseasePrognosismedicine.anatomical_structureSpainMultivariate AnalysisCardiologyFemalemedicine.symptomCardiology and Cardiovascular MedicinebusinessEmergency Service HospitalFollow-Up StudiesThe American journal of cardiology
researchProduct

The joint impact of donor and recipient parameters on the outcome of heart transplantation in Germany after graft allocation.

2013

Organ shortage in heart transplantation (HTx) results in increased use of grafts from donors with substantial risk factors. It is discussed controversially which donor characteristics may be detrimental. Therefore, we evaluated the joint impact of donor- and patient-related risk factors in HTx on patient survival by multiple analysis in a nationwide multicentre study after donor selection was carried out. The research database consists of data concerning hearts donated and transplanted in Germany between 2006 and 2008 as provided by Deutsche Stiftung Organtransplantation and the BQS Institute. Multiple Cox regression (significance level 5%, hazard ratio [95% CI]) was conducted (n = 774, rec…

AdultMalemedicine.medical_specialtyDatabases Factualmedicine.medical_treatmentDonor SelectionYoung AdultRisk FactorsInternal medicineGermanymedicineHumansCause of deathProportional Hazards ModelsHeart transplantationHeart FailureTransplantationbiologyProportional hazards modelDonor selectionbusiness.industryHazard ratioGraft SurvivalAge FactorsMiddle Agedmedicine.diseasePulmonary hypertensionTroponinSurvival AnalysisTissue DonorsSurgerymedicine.anatomical_structureTreatment OutcomeMultivariate AnalysisCardiologyVascular resistancebiology.proteinHeart TransplantationFemalebusinessTransplant international : official journal of the European Society for Organ Transplantation
researchProduct

A multiple biomarker risk score for guiding clinical decisions using a decision curve approach.

2011

Aims: We assessed whether a cardiovascular risk model based on classic risk factors (e.g. cholesterol, blood pressure) could refine disease prediction if it included novel biomarkers (C-reactive protein, N-terminal pro-B-type natriuretic peptide, troponin I) using a decision curve approach which can incorporate clinical consequences. Methods and results: We evaluated whether a model including biomarkers and classic risk factors could improve prediction of 10 year risk of cardiovascular disease (CVD; chronic heart disease and ischaemic stroke) against a classic risk factor model using a decision curve approach in two prospective MORGAM cohorts. This included 7739 men and women with 457 CVD …

AdultMalemedicine.medical_specialtyEpidemiologymedicine.drug_classBlood PressureDiseaseRisk AssessmentDecision Support TechniquesSex FactorsPredictive Value of TestsRisk FactorsInternal medicineTroponin INatriuretic Peptide BrainmedicineNatriuretic peptideHumansRisk thresholdProspective StudiesFramingham Risk Scorebusiness.industryTroponin IAge FactorsMiddle AgedPrognosisPeptide FragmentsSurgeryEuropeBlood pressureC-Reactive ProteinCholesterolCardiovascular DiseasesCohortBiomarker (medicine)FemaleCardiology and Cardiovascular MedicinebusinessBiomarkersEuropean journal of preventive cardiology
researchProduct

Combination of indomethacin and statin compared with indomethacin and placebo in patients with a first episode of acute pericarditis: preliminary fin…

2007

The aim of the present study was to evaluate the safety and efficacy of the combination of indomethacin and statin compared with indomethacin plus placebo in patients with a first episode of pericarditis. A total of 55 consecutive patients with acute pericarditis were randomized in a double-blind manner into two groups: group I (statin group) was treated with 150 mg of indomethacin plus 10 mg of rosuvastatin, and group 2 (placebo group) was treated with 150 mg of indomethacin plus placebo. Both groups received treatment up to the normalization of inflammation markers and for the following week. Clinical and laboratory assessments [white cell count, ESR (erythrocyte sedimentation rate) and C…

AdultMalemedicine.medical_specialtyIndomethacinPlaceboGastroenterologyElectrocardiographyPericarditisAcute pericarditisDouble-Blind MethodRecurrenceInternal medicineTroponin ImedicineHumansPericarditisRosuvastatinRosuvastatin CalciumPericarditis Colchicine Postpericardiotomy syndromeFirst episodeSulfonamidesmedicine.diagnostic_testbiologybusiness.industryAnti-Inflammatory Agents Non-SteroidalCardiovascular AgentsGeneral Medicinemedicine.diseaseSurgeryFluorobenzenesC-Reactive ProteinPyrimidinesTreatment OutcomeErythrocyte sedimentation rateAcute Diseasebiology.proteinDrug Therapy CombinationFemaleCreatine kinaseHydroxymethylglutaryl-CoA Reductase InhibitorsInflammation MediatorsbusinessFollow-Up Studiesmedicine.drugClinical Science
researchProduct